<DOC>
	<DOC>NCT02705833</DOC>
	<brief_summary>The primary objective of the study is to characterize the medical management of squamous cell carcinoma head and neck (SCCHN) patients diagnosed with recurrent/metastatic (R/M) disease (between 01July2013 and 30 June 2014) in the real-world setting.</brief_summary>
	<brief_title>Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>Adult patient (18 years old or older) with a confirmed diagnosis or R/M head and neck, may be living or deceased at time of enrollment in the study Diagnosis of R/M head and neck cancer between 01July2013 and 30June2014 (study index period) If female patient, pregnant or lactating between 01July2013 and 30June2014 Enrolled in cancer treatmentclinical trials since diagnosis of R/M head and neck cancer during the study index period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>